EHIMA welcomes the European Commissions targeted MDR revision and appreciates the opportunity to contribute to this important consultation. EHIMA supports the Commissions efforts to strengthen efficiency, proportionality and legal certainty while maintaining high patient safety standards. The input focuses on reducing fragmentation, improving predictability, and ensuring balanced AI and cybersecurity requirements.
EHIMA
Industry association · Germany · EU Transparency Register 34590331316-73
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #812 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- The organization is a member of the World Hearing Forum of the World Health Organization (https://www.who.int/activit…
- The organization is the provider of the international information portal www.hearingyou.org
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Trade and business associations
- Registered as
- European Hearing Instrument Manufacturers Association (EHIMA)
- Head office
- Frankfurt am Main, Germany
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track EHIMA in PolicySpeak: request access →
Work at EHIMA? so we know who speaks for it.
Their record over time
EHIMA filed 2 positions between 26 Sept 2025 and 11 May 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 2 times.
What they argued
As set out in our earlier submission, the European Hearing Instrument Manufacturers Association (EHIMA) welcomes the opportunity to contribute to the European Commissions stakeholder consultation on the revision of the Medical Device Regulation (MDR). EHIMA urges the European Commission to revise MDR implementation to ensure efficiency, consistency, and risk-based regulation.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from EHIMA’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.